The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2b randomized, blinded, placebo-controlled trial to investigate the efficacy and safety of visugromab added to pembrolizumab, pemetrexed, and carboplatin in first-line metastatic non-squamous NSCLC: GDFATHER-NSCLC-01.
 
Martin Reck
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; GlaxoSmithKline K.K.; IO Biotech; IO Biotech; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Samsung Bioepis; Sanofi/Regeneron
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Sanofi/Aventis
(OPTIONAL) Uncompensated Relationships - “Medical writing assistance for this abstract was provided by Bena Lim, PhD, CMPP, of Nucleus Global, an Inizio Company, and funded by F. Hoffmann-La Roche Ltd.” (Inst); “Medical writing assistance for this abstract was provided by Nimisha H. Bhoola, PhD, of Nucleus Global, an Inizio Company, and funded by F. Hoffmann-La Roche Ltd.” (Inst)
 
Konstantinos Ferentinos
Consulting or Advisory Role - Amgen; BeiGene; Regeneron; Takeda
Travel, Accommodations, Expenses - BeiGene; Johnson & Johnson/Janssen; Lilly
 
Markus Joerger
Stock and Other Ownership Interests - Cair.one
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Roche (Inst)
Research Funding - Anaveon (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); Immunophotonics (Inst); Incyte (Inst); Innomedica (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; PharmaMar; Roche
 
Manuel Cobo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Kyowa Kirin International; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Kyowa Kirin International; Lilly; MSD; Novartis; Novocure; Pierre Fabre; Roche; Sanofi; Takeda
 
Benjamin Thiele
Travel, Accommodations, Expenses - Catalym
 
Manolo D'Arcangelo
No Relationships to Disclose
 
Miguel Sanmamed
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; MSD; Numab
Speakers' Bureau - MSD
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Lilly
 
Mariam Alexander
Consulting or Advisory Role - Abbvie; Amgen; Bayer; Janssen Oncology
Speakers' Bureau - IDEOlogy Health
 
Aakash Desai
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Bristol Myers Squibb; ConcertAI; Daichii Sankyo; Foundation Medicine; Janssen Oncology; Lilly; Merus; Regeneron; Sanofi
 
Jhanelle Gray
Honoraria - Amgen; AstraZeneca; CatalYM; Coherus Biosciences; Daiichi Sankyo, Inc; Flatiron Health; Genentech; Gilead Sciences; GO2 for Lung Cancer; IDEOlogy Health; Janssen Scientific Affairs; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Lilly; Merck; Novartis; Pfizer; Regeneron; Takeda; Zai Lab
Consulting or Advisory Role - Amgen; AstraZeneca; Catalym; Coherus Biosciences; Daiichi Sankyo/UCB Japan; Flatiron Health; Genentech; Gilead Sciences; GO2 for Lung Cancer; IDEOlogy Health; Janssen Scientific Affairs; Jazz Pharmaceuticals; Lilly; Merck; Novartis; Pfizer; Regeneron; Takeda; Zai Lab
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Catalym (Inst); Genentech (Inst); Gilead Services (Inst); GO2 for Lung Cancer (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Panbela Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Roy Herbst
Leadership - American Association for Cancer Research; Friends of Cancer Research; IASLC; Immunocore; Junshi Pharmaceuticals; SWOG
Stock and Other Ownership Interests - Bolt Biotherapeutics; Checkpoint Therapeutics; Immunocore; Normunity
Consulting or Advisory Role - Abbvie; Amgen; ArriVent Biopharma; AstraZeneca; Bristol-Myers Squibb; Candel Therapeutics; Catalym; Checkpoint Therapeutics; Cybrexa Therapeutics; Genentech/Roche; Gilead/Forty Seven; I-Mab; Janssen; Junshi Pharmaceuticals; Lilly; Mediflix; Merck; NEUVOGEN; NextCure; Normunity; Novartis; Pfizer; Regeneron; Roche; Sanofi
Research Funding - AstraZeneca; Genentech/Roche; Lilly; Merck
Travel, Accommodations, Expenses - American Cancer Society; IASLC; SWOG
 
Jorge Nieva
Leadership - AffyImmune Therapeutics
Stock and Other Ownership Interests - Cansera; Epic Sciences; Indee P/L
Consulting or Advisory Role - AADi; ANP Technologies; AstraZeneca; Bioatla; Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Pfizer; Takeda; Urogen pharma
Research Funding - Genentech (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending - movement and unexpected healthcare encounters
 
Rajwanth Veluswamy
Consulting or Advisory Role - Catalym
 
Kathrin Klar
Employment - Catalym
Travel, Accommodations, Expenses - Catalym
 
Marlene Fox
Employment - Catalym
 
Vanja Radulovic
Employment - Catalym
 
Lena Lemke
Employment - BioNTech; Catalym; Sandoz
Stock and Other Ownership Interests - Novartis
 
Eugen Leo
Employment - Catalym
Leadership - Catalym
Stock and Other Ownership Interests - Catalym
 
Sujata Rao
Employment - Catalym; InSilico Medicine
Leadership - Catalym; InSilico Medicine
 
Felix Lichtenegger
Employment - CatalYm; T-Knife